Continued Access to RXDX-105

Clinical trial NCT03784378 · COMPLETED

Trial details

NCT number: NCT03784378
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Ovarian Cancer RET Gene Mutation BRAF Gene Mutation

Start date: 2018-12-14
Primary completion: 2020-09-30
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.